Does ALIROCUMAB Cause Secretion discharge? 129 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Secretion discharge have been filed in association with ALIROCUMAB (Praluent). This represents 0.6% of all adverse event reports for ALIROCUMAB.
129
Reports of Secretion discharge with ALIROCUMAB
0.6%
of all ALIROCUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Secretion discharge From ALIROCUMAB?
Of the 129 reports, 1 (0.8%) required hospitalization.
Is Secretion discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Secretion discharge?
ADALIMUMAB (685)
DUPILUMAB (626)
ALBUTEROL (520)
OMALIZUMAB (514)
ETANERCEPT (487)
METHOTREXATE (387)
MEPOLIZUMAB (359)
BUDESONIDE\FORMOTEROL (339)
PREDNISONE (316)
SECUKINUMAB (307)
Which ALIROCUMAB Alternatives Have Lower Secretion discharge Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN